Skip to Main content Skip to Navigation
Journal articles

Leishmaniavirus genetic diversity is not related to leishmaniasis treatment failure

Abstract : OBJECTIVES: The outcome of American tegumentary leishmaniasis (ATL) may depend on the presence of the Leishmania RNA virus (LRV). This virus may be involved in treatment failure. We aimed to determine whether genetic clusters of LRV1 are involved in this therapeutic outcome. METHODS: The presence of LRV1 was assessed in 129 L. guyanensis isolates from patients treated with pentamidine in French Guiana. Among the 115 (89%) isolates found to carry LRV1, 96 were successfully genotyped. Patient clinical data were linked to the LRV data. RESULTS: The rate of treatment failure for LRV1-positive isolates was 37% (15/41) versus 40% (2/5) among LRV1-negative isolates (p = 0.88). Concerning LRV1 genotypes, two predominant LRV1 groups emerged, groups A (23% (22/96)) and B (70% (67/96)). The treatment failure rate was 37% (3/8) for group A and 45% (9/20) for group B (p = 0.31). CONCLUSION: Neither the presence or genotype of LRV1 in patients with L. guyanensis seemed to correlate with pentamidine treatment failure.
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02569704
Contributor : Isabelle Combe <>
Submitted on : Monday, May 11, 2020 - 3:05:51 PM
Last modification on : Thursday, May 14, 2020 - 1:18:12 AM

Identifiers

Collections

Citation

Marine Ginouves, Pierre Couppié, Stéphane Simon, Eliane Bourreau, Stéphanie Rogier, et al.. Leishmaniavirus genetic diversity is not related to leishmaniasis treatment failure. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2020, pp.S1198-743X(20)30265-2. ⟨10.1016/j.cmi.2020.04.037⟩. ⟨hal-02569704⟩

Share

Metrics

Record views

45